{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:54:42Z","timestamp":1793390082284,"version":"4.5.0"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Approximately 800 women die from pregnancy or childbirth-related complications around the world every day, 99% of which occur in developing countries. In majority of cases deaths are related to pre-eclampsia and eclampsia. The purpose of new adjusted and simplified IAPM guidelines is specifically lowering maternal mortality by decreasing preventable deaths in developing countries (particularly in remote rural areas) by using rather cheap\u00a0medicines used to control chronic and gestational hypertension, prevent pre-eclampsia in high-risk pregnancies and treat severe pre-eclampsia and eclampsia. IAPM guidelines should be implemented and evaluated in\u00a0each developing country respecting specific problems, needs and resources. It is of essential importance to: 1.\u00a0Identify specific high-risk pregnancies, 2. Commence timely appropriate ASA and calcium supplementation, 3.\u00a0Organize basic antenatal care and adequate referral of pregnancies with early onset of pre-eclampsia to the appropriate institutions and ensure induction of labour in\u00a0well-equipped delivery facility for women with near-term and term pre-eclampsia 4. Ensure magnesium sulphate availability to prevent severe pre-eclampsia and eclampsia-related maternal deaths, and 5. Identify specific barriers for implementation of these guidelines and correct them accordingly. Only by systematic implementations of these guidelines, we may have a chance to decrease the mortality of pre-eclampsia an its complications as a killer number one of mothers in developing countries.<\/jats:p>","DOI":"10.1515\/jpm-2021-0636","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T21:26:26Z","timestamp":1640294786000},"page":"164-169","source":"Crossref","is-referenced-by-count":14,"title":["International Academy of Perinatal Medicine (IAPM) guidelines for screening, prediction, prevention and management of pre-eclampsia to reduce maternal mortality in developing countries"],"prefix":"10.1515","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-1698","authenticated-orcid":false,"given":"Vedran","family":"Stefanovic","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology , Fetomaternal Medical Center, Helsinki University Hospital and University of Helsinki , Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"2023040100500945647_j_jpm-2021-0636_ref_001","doi-asserted-by":"crossref","unstructured":"Brown, MA, Magee, LA, Kenny, LC, Karumanchi, SA, McCarthy, FP, Saito, S, et al.. International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018;72:24\u201343. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10803.","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_002","doi-asserted-by":"crossref","unstructured":"Dhanda, S, Ramani, S, Thakur, M. Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management. Radiol Res Pract 2011;2014:842751. https:\/\/doi.org\/10.1155\/2014\/842751.","DOI":"10.1155\/2014\/842751"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_003","unstructured":"World Health Organization. Sexual and Reproductive Health (Internet). WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Published 2011 (updates 2018). WHO ref nro: WHO\/RHR\/11.30. Available from: https:\/\/www.who.int\/reproductivehealth\/publications\/maternal_perinatal_health\/9789241548335\/en\/."},{"key":"2023040100500945647_j_jpm-2021-0636_ref_004","doi-asserted-by":"crossref","unstructured":"Gaym, A, Bailey, P, Pearson, L, Admasu, K, Gebrehiwot, Y. Disease burden due to pre-eclampsia\/eclampsia and the Ethiopian health system\u2019s response. Int J Gynecol Obstet 2011;115:112\u20136.","DOI":"10.1016\/j.ijgo.2011.07.012"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_005","unstructured":"Ragasudha, C, Madhavi, AP, Sharon, PS, Priya, S, Shehnaz, S. A study of maternal deaths from preeclampsia and eclampsia in a tertiary care centre. IAIM 2018;5:6\u201310."},{"key":"2023040100500945647_j_jpm-2021-0636_ref_006","doi-asserted-by":"crossref","unstructured":"Abalos, E, Cuesta, C, Carroli, G, Qureshi, Z, Widmer, M, Vogel, JP. Souza JP on behalf of the WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre\u2010eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization multicountry survey on maternal and newborn health. BJOG 2014;121(1 Suppl):14\u201324. https:\/\/doi.org\/10.1111\/1471-0528.12629.","DOI":"10.1111\/1471-0528.12629"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_007","doi-asserted-by":"crossref","unstructured":"Sotiriadis, A, Hernandez-Andrade, E, da Silva Costa, F, Ghi, T, Glanc, P, Khalil, A, et al.. ISUOG CSC Pre-eclampsia Task Force. ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol 2019;53:7\u201322. https:\/\/doi.org\/10.1002\/uog.20105.","DOI":"10.1002\/uog.20105"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_008","doi-asserted-by":"crossref","unstructured":"Poon, LC, Shennan, A, Hyett, JA, Kapur, A, Hadar, E, Divakar, H, et al.. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 2019;145(1 Suppl):1\u201333. Erratum in: Int J Gynaecol Obstet. 2019 Sep;146(3):390\u20131. https:\/\/doi.org\/10.1002\/ijgo.12802.","DOI":"10.1002\/ijgo.12892"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_009","doi-asserted-by":"crossref","unstructured":"Bartsch, E, Medcalf, KE, Park, AL, Ray, JG. On behalf of the High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ (Internet) 2016;353:i1753. https:\/\/doi.org\/10.1136\/bmj.i1753.","DOI":"10.1136\/bmj.i1753"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_010","doi-asserted-by":"crossref","unstructured":"Rolnik, DL, Wright, D, Poon, LC, O\u2019Gorman, N, Syngelaki, A, de Paco Matallana, C, et al.. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377:613\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1704559.","DOI":"10.1056\/NEJMoa1704559"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_011","doi-asserted-by":"crossref","unstructured":"Smits, J, Monden, C. Twinning across the developing world. PLoS One 2011;6:e25239. https:\/\/doi.org\/10.1371\/journal.pone.0025239.","DOI":"10.1371\/journal.pone.0025239"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_012","doi-asserted-by":"crossref","unstructured":"Kalafat, E, Shirazi, A, Thilaganathan, B, Khalil, A. The role of aspirin in prevention of preeclampsia in twin pregnancies: does the dose matter? Am J Obstet Gynecol 2020;223:457\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2020.03.005.","DOI":"10.1016\/j.ajog.2020.03.005"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_013","doi-asserted-by":"crossref","unstructured":"Imdad, A, Jabeen, A, Bhutta, ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Publ Health 2011;11(3 Suppl):S18. https:\/\/doi.org\/10.1186\/1471-2458-11-S3-S18.","DOI":"10.1186\/1471-2458-11-S3-S18"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_014","doi-asserted-by":"crossref","unstructured":"Omotayo, MO, Dickin, KL, O\u2019Brien, KO, Neufeld, LM, De Regil, LM, Stoltzfus, RJ. Calcium supplementation to prevent preeclampsia: translating Guidelines into practice in low-income countries. Adv Nutr 2016;7;275\u20138. https:\/\/doi.org\/10.3945\/an.115.010736.","DOI":"10.3945\/an.115.010736"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_015","unstructured":"World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia: evidence base. World Health Organization; 2011. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/70731."},{"key":"2023040100500945647_j_jpm-2021-0636_ref_016","unstructured":"WHO recommendations on drug treatment for non-severe hypertension in pregnancy [Internet]. Geneva: World Health Organization; 2020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK561247\/."},{"key":"2023040100500945647_j_jpm-2021-0636_ref_017","doi-asserted-by":"crossref","unstructured":"Ridge, AL, Bero, LA, Hill, SR. Identifying barriers to the availability and use of magnesium sulphate injection in resource poor countries: a case study in Zambia. BMC Health Serv Res 2010;10:340. https:\/\/doi.org\/10.1186\/1472-6963-10-340.","DOI":"10.1186\/1472-6963-10-340"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_018","doi-asserted-by":"crossref","unstructured":"Chollat, C, Marret, S. Magnesium sulfate and fetal neuroprotection: overview of clinical evidence. Neural Regen Res 2018;13:2044\u20139. https:\/\/doi.org\/10.4103\/1673-5374.241441.","DOI":"10.4103\/1673-5374.241441"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_019","doi-asserted-by":"crossref","unstructured":"WHO ACTION Trials Collaborators, Oladapo, OT, Vogel, JP, Piaggio, G, Nguyen, M-H, Althabe, F, et al.. Antenatal dexamethasone for early preterm birth in low-resource countries. N Engl J Med 2020;383:2514\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2022398.","DOI":"10.1056\/NEJMoa2022398"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_020","doi-asserted-by":"crossref","unstructured":"Stefanovic, V. Role of obstetric ultrasound in reducing maternal and neonatal mortality in developing countries: from facts to acts. Donald Sch J Ultrasound Obstet Gynecol 2020;14:43\u20139. https:\/\/doi.org\/10.5005\/jp-journals-10009-1617.","DOI":"10.5005\/jp-journals-10009-1617"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_021","doi-asserted-by":"crossref","unstructured":"Akeju, DO, Vidler, M, Oladapo, OT, Sawchuck, D, Qureshi, R, von Dadelszen, P, et al.. Community perceptions of pre-eclampsia and eclampsia in Ogun State, Nigeria: a qualitative study. Reprod Health 2016;13(1 Suppl):57. https:\/\/doi.org\/10.1186\/s12978-016-0134-z.","DOI":"10.1186\/s12978-016-0134-z"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_022","doi-asserted-by":"crossref","unstructured":"Olaoye, T, Oyerinde, OO, Elebuji, OJ, Ologun, O. Knowledge, perception and management of pre-eclampsia among health care providers in a maternity hospital. Int J MCH AIDS 2019;8:80\u20138. https:\/\/doi.org\/10.21106\/ijma.275.","DOI":"10.21106\/ijma.275"},{"key":"2023040100500945647_j_jpm-2021-0636_ref_023","doi-asserted-by":"crossref","unstructured":"Savage, AR, Hoho, L. Knowledge of pre-eclampsia in women living in Makole Ward, Dodoma, Tanzania. Afr Health Sci 2016;16:412\u20139. https:\/\/doi.org\/10.4314\/ahs.v16i2.9.","DOI":"10.4314\/ahs.v16i2.9"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2021-0636\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2021-0636\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T16:50:30Z","timestamp":1680367830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2021-0636\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,31]]},"published-print":{"date-parts":[[2023,2,23]]}},"alternative-id":["10.1515\/jpm-2021-0636"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2021-0636","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]}}}